Every high-volume clinical program is sitting on data no single trial can buy. Most departments file it under clinical revenue instead of research infrastructure. That is a strategic miss.
The Department of Internal Medicine at UTMB is hiring a Vice Chair for Research. In two years we've hired more than a hundred faculty and five Division Chiefs, and filled three of five Vice Chair seats. Research is one of the two still open.
1/ HOT OFF THE PRESS: The first randomized test of lipoprotein(a) has failed, and it should not be a shock. Pelacarsen lowered Lp(a) in 8,323 patients with a prior heart attack, stroke, or peripheral artery disease. Cardiovascular events did not fall.
A faculty member left a department I know well. The exit interview blamed pay. It wasn't. She'd told three colleagues she felt like an interchangeable part. Salary was competitive. Belonging wasn't. That gap is where most academic-medicine attrition actually lives.
Out now in JCEM, multicenter study from the International Study of Inflammation in #COVID19, @CardiacLab, @umich exploring the mediating role of #inflammation between obesity and outcomes across the Covid-19 pandemic in 4,644 hospitalized patients. 1/4🧵
https://t.co/irtSvmeXjU
Check out our new paper published in @JAHA_AHA examining the rates of immune-checkpoint inhibitor myocarditis throughout the COVID-19 pandemic! ❤️🦠
📒https://t.co/L2OhqXjrqw
4/7 The International Study of Inflammation in #Covid is now published @wileymicrobio. This multicenter cohort study of over 3000 #Covid-19 patients evaluated the prognostic ability of various biomarkers. #suPAR outperformed others including CRP and IL-6. https://t.co/9ez0NFS0Yp
3/7 For a comprehensive review of suPAR's role in cardiovascular diseases, I recommend @Anis__Ismail's review. It provides a thorough overview of the current data and insights. https://t.co/5UsyoWAW5I
Do you have flu-like symptoms? 😷
You may be eligible for our newest research study with @HealgenSci
Follow the link below to find out more information.
https://t.co/Rjfd3nUccV
@Avasbind@salimhayek + team @umichCVC developed the CARE-BMT Risk Score to predict cardiovascular events in hematopoietic stem cell transplant recipients.
Learn how to stratify patients' risk before bone marrow transplant👇. #AHAJournals#CardioOncology https://t.co/HIiuDcufWb
Read our most recent work published in @JAHA_AHA! The CARE-BMT risk score can help identify patients at high risk of developing cardiovascular events prior to undergoing stem cell transplant. This is the first pre-transplant risk stratification tool!
https://t.co/ZNyB2YlSJu
Holiday celebration at @CardiacLab feels like a gathering of more than just colleagues. It’s a blend of friendship, support, and shared passion for what we do. Every person here has enriched my life in a unique way. Grateful doesn’t even begin to cover it.